Perseus Proteomics Inc.
HOMECorporate ProfileResearch & DevelopmentProduct Information
Corporate Profile
News
2018/3/30
PPMX received 1.4 billion yen from Nippon Venture Capital Co.,Ltd. and other capitals in a third party allocation of shares.
Perseus Proteomics Inc.


PPMX received 1.4 billion yen from Nippon Venture Capital Co.,Ltd. and other capitals in a third party allocation of shares.

PPMX received 1.4 billion yen from Nippon Venture Capital Co.,Ltd. and other capitals in a third party allocation of shares.
We will make further effort to develop therapeutic antibodies and related products.